
Antisense Oligonucleotides: Programming RNA to Silence Disease | GeneInCell | 2026
2026-06-15
0:00
57:13
Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules bind target RNA to reduce harmful protein production, reshape splicing, and open new possibilities for precision therapeutics. We cover the history, mechanism, chemistry, and growing clinical relevance of ASOs, along with their promise and limitations in treating genetic, neurological, retinal, muscular, liver, and rare diseases.
Fler avsnitt från "GeneInCell"



Missa inte ett avsnitt av “GeneInCell” och prenumerera på det i GetPodcast-appen.








